Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5067425 | 0.83 | ADRB2 (0.38) | ALDH1A1TP53 | |
| SCHEMBL8650786 | 0.81 | ALDH1A1 (0.47) | ALDH1A1TP53 | |
| SCHEMBL109401 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TP53 | |
| SCHEMBL11615347 | 0.79 | THRB (0.38) | ALDH1A1 | |
| SCHEMBL9329827 | 0.79 | THRB (0.38) | ALDH1A1 | |
| SCHEMBL9329868 | 0.79 | THRB (0.38) | ALDH1A1 | |
| SCHEMBL8648542 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TP53 | |
| SCHEMBL3899065 | 0.78 | ADRB2 (0.38) | ALDH1A1TP53 | |
| SCHEMBL30420061 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TP53 | |
| SCHEMBL11677357 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1882694-B1 | OLIGOMERS AND POLYMERS OF THIOPHENE COMPOUNDS HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME | NISSAN CHEMICAL IND LTD (JP) | 2013-04-03 | — | — | EP | disclosed |
| CN-101208349-B | Thiophene compound having phosphate ester and method for producing same | NISSAN CHEMICAL IND LTD | 2012-06-06 | — | — | CN | disclosed |
| CN-101208349-A | Thiophene compound having phosphate ester and method for producing same | NISSAN CHEMICAL IND LTD (JP) | 2008-06-25 | — | — | CN | disclosed |
| EP-1882694-A1 | THIOPHENE COMPOUND HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME | Nissan Chemical Industries, Ltd. (JP) | 2008-01-30 | — | — | EP | disclosed |
| EP-1318155-B1 | Novel asymmetric phosphine ligand | TAKASAGO PERFUMERY CO LTD (JP) | 2005-03-23 | — | — | EP | disclosed |
| US-6624320-B2 | Phosphorane compound hydrogenation catalyts; stereospecific; catalyst selectivity | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-09-23 | — | — | US | disclosed |
| US-20030144138-A1 | NOVEL ASYMMETRIC PHOSPHINE LIGAND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-07-31 | — | — | US | disclosed |
| EP-1318155-A1 | Novel asymmetric phosphine ligand | Takasago International Corporation (JP) | 2003-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144138-A1 | NOVEL ASYMMETRIC PHOSPHINE LIGAND | PHOSPHO1, PLCG2, PLCB3 | ALDH1A1 2360/4885TP53 3156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.